ArticleMolecular therapy. Oncology2026

Ligand-based CAR design enhances durability of CD70-targeted CAR T cells in glioblastoma.

Florian Strassheimer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.